Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Sangamo Therapeutics (SGMOQ) Cash & Current Investments (2009 - 2026)

Updated

Sangamo Therapeutics (SGMOQ) posted Cash & Current Investments of $27.6 million for Q1 2026, up 9.6% from $25.18 million a year earlier and up 31.8% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Sangamo Therapeutics' Cash & Current Investments came in at $20.95 million, down 50.0% from FY2024.

  • Annual Cash & Current Investments has declined for five consecutive years, with a five-year compound annual growth rate of -49.6% (FY2020 to FY2025).
  • In prior years, Sangamo Therapeutics' Cash & Current Investments was $41.92 million in FY2024 (-48.3%), $81 million in FY2023 (-70.8%), $277.63 million in FY2022 (-26.3%) and $376.55 million in FY2021 (-41.3%).
  • Quarterly Cash & Current Investments has run from a low of $20.95 million in Q4 2025 to a high of $529.65 million in Q2 2021 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 35.0%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2025, with growth of 38.0%; the weakest was Q2 2024, with a decline of 80.6%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $20.95 million (Q4 2025), $29.62 million (Q3 2025) and $38.34 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Sangamo Therapeutics 45.57 Mn -70.94 Mn - 27.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 27.60 Mn
Dec 31, 2025 20.95 Mn
Sep 30, 2025 29.62 Mn
Jun 30, 2025 38.34 Mn
Mar 31, 2025 25.18 Mn
Dec 31, 2024 41.92 Mn
Sep 30, 2024 39.20 Mn
Jun 30, 2024 27.79 Mn
Mar 31, 2024 54.42 Mn
Dec 31, 2023 81.00 Mn
Sep 30, 2023 132.11 Mn
Jun 30, 2023 143.10 Mn
Mar 31, 2023 205.39 Mn
Dec 31, 2022 277.63 Mn
Sep 30, 2022 313.57 Mn
Jun 30, 2022 315.72 Mn
Mar 31, 2022 317.80 Mn
Dec 31, 2021 376.55 Mn
Sep 30, 2021 423.41 Mn
Jun 30, 2021 529.65 Mn
API Access

Sangamo Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY